Lilly and German biotech Seamless Therapeutics will develop recombinase-based treatments for hearing loss. In a move that ...

Real-world evidence (RWE) empowers payers and providers to make more informed, cost-effective treatment. Read more here: ...

Ocado is adapting its advanced grocery fulfilment technology for pharmaceutical warehousing. Here's what it wants to achieve.

This year, sales of Eliquis (apixaban) are projected to decline by 15.2% due to the loss of its European market exclusivity ...

The 15 drugs accounted for $27bn in spending via Medicare Part B and Part D between November 2024 and October 2025.

The US FDA has accepted for priority review Otsuka Pharmaceutical’s NDA submitted for centanafadine, an investigational, once-daily extended-release capsule for ADHD treatment.

Insilico Medicine has entered a strategic partnership with Qilu Pharmaceutical to develop treatments for cardiometabolic ...

Other countries in Europe to lose eliminated status include Armenia, Austria, Azerbaijan, Spain, and Uzbekistan. Sustained ...

Eisai and Biogen have announced that the US FDA has accepted for review the sBLA submitted by the former for Leqembi Iqlik SC ...

A new report has revealed that 83% of life sciences CEOs view Internet of Medical Things (IoMT) devices as the most important capability towards driving growth, accelerating R&D, and unlocking ...

The lack of initial public offerings (IPOs) also reflects a year of restricted growth. As per the BIA, no UK biotechs went ...